(Q37305111)

19 August 2017

1 reference

title

Role of acetyl-L-carnitine in the treatment of diabetic peripheral neuropathy (English)

1 reference

19 August 2017

Jeffery D Evans

1

1 reference

19 August 2017

Tibb F Jacobs

series ordinal

2

1 reference

19 August 2017

Emily W Evans

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

21 October 2008

1 reference

Annals of Pharmacotherapy

19 August 2017

published in

1 reference

19 August 2017

volume

42

1 reference

19 August 2017

issue

11

1 reference

19 August 2017

page(s)

1686-1691

1 reference

Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

19 August 2017

cites work

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

Neuropathic pain: a practical guide for the clinician

21 January 2018

1 reference

Disorders of carnitine transport and the carnitine cycle

21 January 2018

1 reference

Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism

21 January 2018

1 reference

Carnitine--metabolism and functions

21 January 2018

1 reference

Carnitine deficiency in children and adolescents with type 1 diabetes

21 January 2018

1 reference

L-carnitine improves glucose disposal in type 2 diabetic patients

21 January 2018

1 reference

Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus

21 January 2018

1 reference

Pharmacological enhancement of peripheral nerve regeneration in the rat by systemic acetyl-L-carnitine treatment

21 January 2018

1 reference

Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.

21 January 2018

1 reference

L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors

21 January 2018

1 reference

Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1L201

1 reference

19 August 2017

1 reference